Per Kristian Eide1, Are Hugo Pripp2, Geir A Ringstad3. 1. Dept. of Neurosurgery, Oslo University Hospital-Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: p.k.eide@medisin.uio.no. 2. Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. 3. Dept. of Radiology and Nuclear Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Abstract
BACKGROUND: While most pineal cysts (PCs) are asymptomatic, some PCs are accompanied with symptoms of variable severity. We suggested that symptom severity in symptomatic patients with non-hydrocephalic PCs relates to venous compression causing central venous hypertension. This study explored whether possible magnetic resonance imaging (MRI) biomarkers of central venous hypertension could differentiate the severity of symptoms in individuals with non-hydrocephalic PCs. METHODS: The study included all individuals with PCs and MRI available for analysis followed conservatively within the department from 2003 to 2014. Severity of symptoms at follow-up were assessed from a questionnaire. Suggested MRI biomarkers indicative of central venous hypertension were explored, in addition to MRI measures of cyst size, aqueduct stenosis, and tectal compression. RESULTS: The study included 66 patients. As compared to the 27/66 patients (41%) with "None-Moderate" symptoms at follow-up, the 39/66 patients (59%) with "Much-Severe" symptoms presented with significantly altered indices of central venous hypertension (tectum-splenium-cyst ratio and indices of thalamic and periventricular edema). PC grading based on MRI biomarkers of central venous hypertension differentiated the severity of symptoms. CONCLUSION: The results indicate an association between severity of symptoms and MRI biomarkers of central venous hypertension in symptomatic individuals with non-hydrocephalic PCs.
BACKGROUND: While most pineal cysts (PCs) are asymptomatic, some PCs are accompanied with symptoms of variable severity. We suggested that symptom severity in symptomatic patients with non-hydrocephalic PCs relates to venous compression causing central venous hypertension. This study explored whether possible magnetic resonance imaging (MRI) biomarkers of central venous hypertension could differentiate the severity of symptoms in individuals with non-hydrocephalic PCs. METHODS: The study included all individuals with PCs and MRI available for analysis followed conservatively within the department from 2003 to 2014. Severity of symptoms at follow-up were assessed from a questionnaire. Suggested MRI biomarkers indicative of central venous hypertension were explored, in addition to MRI measures of cyst size, aqueduct stenosis, and tectal compression. RESULTS: The study included 66 patients. As compared to the 27/66 patients (41%) with "None-Moderate" symptoms at follow-up, the 39/66 patients (59%) with "Much-Severe" symptoms presented with significantly altered indices of central venous hypertension (tectum-splenium-cyst ratio and indices of thalamic and periventricular edema). PC grading based on MRI biomarkers of central venous hypertension differentiated the severity of symptoms. CONCLUSION: The results indicate an association between severity of symptoms and MRI biomarkers of central venous hypertension in symptomatic individuals with non-hydrocephalic PCs.
Authors: C S Edeklev; M Halvorsen; G Løvland; S A S Vatnehol; Ø Gjertsen; B Nedregaard; R Sletteberg; G Ringstad; P K Eide Journal: AJNR Am J Neuroradiol Date: 2019-07-18 Impact factor: 3.825
Authors: Riccardo Masina; Ali Ansaripour; Vladimír Beneš; Moncef Berhouma; Joham Choque-Velasquez; Per Kristian Eide; Stepan Fedorko; Steffen Fleck; Juha Hernesniemi; Andrzej Koziarski; Martin Májovský; Andrzej Podgorski; Henry Schroeder; Charles Teo; Andreas W Unterberg; Jacky T Yeung; Angelos Kolias; Thomas Santarius Journal: Acta Neurochir (Wien) Date: 2021-12-02 Impact factor: 2.216
Authors: Steffen Fleck; Ahmed El Damaty; Ina Lange; Marc Matthes; Ehab El Rafaee; Sascha Marx; Jörg Baldauf; Henry W S Schroeder Journal: Neurosurg Rev Date: 2022-07-12 Impact factor: 2.800